Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Panic Attack Treatment Market Size Outlook: How Fast Will Revenue Grow Through 2030?
Witnessing substantial expansion, the market for panic attack treatments has experienced significant recent growth. Projections indicate continued ascendance, with the market value set to increase from $3.58 billion in 2025 to $4.21 billion in 2026, reflecting a compound annual growth rate of 17.6%. Factors contributing to this historical upswing include a nascent understanding of available treatments, a prevailing inclination towards traditional in-person therapeutic approaches, the considerable expense associated with specialized pharmaceuticals, a dispersed network of mental healthcare services, and a slow uptake of virtual therapeutic technologies.
The market for panic attack treatments is poised for considerable expansion in the coming years, projecting a valuation of $7.97 billion by 2030, fueled by a compound annual growth rate of 17.3%. This anticipated expansion owes much to the increasing embrace of telehealth services, the burgeoning fields of virtual reality and digital therapeutics, a rise in anxiety and panic disorder diagnoses, progress in tailored medical approaches, and the widening reach of online pharmacies and hospital networks. Key developments shaping this period include a growing trend towards telepsychiatry and mHealth applications, the incorporation of virtual reality for panic disorder management, a greater reliance on neurofeedback and biofeedback methods, the development of individualized treatment plans, and the broader availability of mental health services in clinics and hospitals.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24356&type=smp
Panic Attack Treatment Market Industry Drivers: What Is Driving Revenue Growth?
With the rising incidence of anxiety anticipated to fuel advancements in the panic attack treatment sector, the market is poised for expansion; anxiety, a condition marked by persistent unease, apprehension, and dread, frequently manifests with physical manifestations like agitation, a quickened pulse, and impaired focus, while contemporary life’s demands for perpetual high performance, fiscal security, and social achievement, with minimal respite for recuperation or emotional regulation, intensify these anxieties, consequently, treatments for panic attacks offer viable avenues for symptom relief, fostering enhanced emotional health, and empowering individuals to reclaim command of their lives through tailored and prompt therapeutic actions, further substantiating this trend, survey data from May 2024, as reported by the American Psychiatric Association, an organization representing American psychiatrists, indicates a significant uptick in anxiety among U.S. adults, with 43% reporting elevated anxiety in 2024, contrasting with 37% in 2023 and 32% in 2022, underscoring how the escalating presence of anxiety is stimulating the panic attack treatment market.
Panic Attack Treatment Market Segmentation And Category Breakdown
The panic attack treatment market covered in this report is segmented –
1) By Treatment Type: Cognitive Behavioral Therapy (CBT), Medications, Other Treatment Types
2) By Drug Class: Antidepressants, Anti-Anxiety Drugs, Calcitonin Gene-Related Peptide (CGRP) Antagonists, Other Drug Classes
3) By Route Of Administration: Oral, Sublingual, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By Application: Hospitals, Mental Healthcare Centers, Other Applications
Subsegments:
1) By Cognitive Behavioral Therapy (CBT): Exposure Therapy, Dialectical Behavior Therapy (DBT), Acceptance And Commitment Therapy (ACT), Mindfulness-Based Cognitive Therapy (MBCT), Rational Emotive Behavior Therapy (REBT)
2) By Medications: Beta Blockers, Buspirone, Anticonvulsants, Atypical Antipsychotics, Herbal And Natural Supplements
3) By Other Treatment Types: Telepsychiatry, Biofeedback And Neurofeedback, Virtual Reality Therapy, Mobile Health Applications, Support Groups And Counseling Services
#Panic Attack Treatment Market Growth Trends: What Is Influencing The Future Outlook?
The leading entities in the panic attack treatment sector are dedicating their efforts to pioneering enhancements in medical technology, notably through the creation of digital anxiety relief platforms, aiming to improve how anxiety and panic attacks are handled by offering convenient, tech-enabled approaches. These digital anxiety relief platforms function as tech-driven applications or services that assist individuals in controlling and alleviating anxiety by providing features like guided meditation, modules for cognitive behavioral therapy, mood monitoring, and relaxation practices. A prime illustration of this trend occurred in October 2024, when CalmiGo, a mental health innovator based in the United States, introduced CalmiGo Plus, a sophisticated digital platform engineered to empower users in managing anxiety and panic attacks with greater efficacy. This platform integrates a patented exhaler device equipped with sensors alongside a complementary mobile app that employs gamified elements and tailored therapeutic methods to foster better mental health results. Such advancements offer users the benefit of instant, non-pharmacological relief while simultaneously allowing them to monitor their progress longitudinally, signifying a major stride in readily available and evidence-based strategies for anxiety treatment.
Panic Attack Treatment Market Competitive Analysis Of Major Industry Participants
Major companies operating in the panic attack treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann‑La Roche Ltd., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma, Lundbeck A/S, Torrent Pharmaceuticals Ltd., Merck & Co Inc., Bristol‑Myers Squibb Company, Otsuka Pharmaceutical Co Ltd, Boehringer Ingelheim International GmbH, Allergan plc, Alkermes plc, Jazz Pharmaceuticals plc, Bayer AG, Amgen Inc., Cipla Limited
Access The Complete Panic Attack Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/panic-attack-treatment-global-market-report
Panic Attack Treatment Market Regional Analysis: Which Region Leads By Revenue?
North Americawas the largest region in the panic attack treatment market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the panic attack treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
